TAIWAN-CHINA-SEMICONDUCTORS-COMPUTERS-TECHNOLOGY

Nvidia’s Jensen Huang during a news conference in Taipei (I-Hwa Cheng/Getty Images)

Malaysia tightens export controls on US AI chips as Nvidia’s Jensen Huang heads to China

It’s part of a US campaign to keep powerful processors out of the hands of its top geopolitical rival.

7/14/25 9:31AM

Malaysia’s Ministry of Investment, Trade, and Industry is now requiring permits for any exports of AI chips of US origin.

The statement doesn’t reference China by name, but this is all about a continued pressure campaign by the US to keep powerful processors out of the hands of its top geopolitical rival. This comes after reports last week suggesting the Trump administration would move more aggressively toward curbing China’s access to AI chips by cracking down on any disguised transshipments from the likes of Malaysia and Thailand. However, it should be noted that this issue was not directly raised in the tariff letters President Trump sent to either nation.

On a related note, Nvidia CEO Jensen Huang is in China this week and scheduled to hold a media briefing in Beijing on July 16.

Nvidia’s inability to sell AI chips to China (following the ban on H20 chip sales) has become a much-bemoaned subject for the company, which referenced the world’s second-largest economy 27 times during its most recent earnings call, more than the previous four quarters combined.

In an interview with Fareed Zakaria that aired this weekend, Huang was asked about the potential for China to use Nvidia’s chips to bolster its military prowess.

“We don’t have to worry about it,” he said. “They simply can’t rely on it. It could be, of course, limited at any time.”

Nate Becker

Oil jumps, stock futures fall as tensions rise and US fires shots at Iranian ship in Strait of Hormuz

The state of the war in Iran is at its most tenuous point since the ceasefire began.

Tasha Matsumoto, Matt Phillips

4/17/26

The S&P 500, Nasdaq 100, and Russell 2000 close at record highs again as Strait of Hormuz is declared open

Stocks reached new record highs as risk-on sentiment flooded back into the markets, while oil tumbled.

Chicago Bulls players Dennis Rodman (L), Scottie Pippen (C) and Michael Jordan (R) hold three of the team's four recent Larry O'Brien trophies 18 June at a rally for the team in Grant Park in Chicago.

Matt Phillips4/17/26

With their recent surge, Intel shares just hit their highest level since the dot-com era

Intel’s surge of nearly 60% this month has the iconic American chipmaker’s stock price approaching levels last seen during the dot-com era. Bloomberg noted that shares just touched their highest intraday level since the turn of the century:

“The stock rose as much as 1.5% to $69.55, topping a peak it hit on Jan. 24, 2020. The shares are up 90% this year, after soaring 84% in 2025. Intel is now roughly 8% from its all-time closing high of $74.88, established on Aug. 31, 2000.”

That’s just the most recent late-’90s-era throwback we’ve been seeing in tech shares lately. Oracle is currently pacing for its best week since late 1999.

What’s even more remarkable, however, is that Intel’s forward price-to-earnings ratio today dwarfs the premiums the market was putting on the stock during the nuttiness of the dot-com mania.

That reflects the fact that the recent run-up in Intel shares is, essentially, giving the chip giant credit for a massive turnaround that hasn’t actually happened yet.

One also might wonder if the fact that Intel is partially owned by the US government means it’s more attractive — and therefore worth a higher premium — than other chipmakers without the state imprimatur.

Still, kind of startling.

Jake Paul v Anthony Joshua - Fighter Showcase & Open Workout

Netflix sinks following disappointing outlook as investors wait for more ad growth

Netflix shares are down more than 10% on Friday morning.

Max Knoblauch4/17/26

J. Edward Moreno4/17/26

Eli Lilly’s GLP-1 pill hit nearly 1,400 prescriptions in first week

Eli Lilly rose after preliminary numbers cited by Wall Street analysts showed strong uptake of its new weight-loss pill.

The FDA approved Foundayo on April 1 and shipments began on April 9. In its first week, roughly 1,400 US prescriptions were written for the drug, according to IQVIA data cited by Deustche Bank analysts in a Friday note.

Novo Nordisk, Lilly’s rival in the GLP-1 market, released its GLP-1 pill earlier this year, and early signs show that it’s expanding the market, inviting patients who were turned off by weekly injections. Novo’s pill had a stronger first week than Lilly’s, with its Wegovy pill hitting 3,071 US prescriptions in the first four days after its launch on January 5.

Lilly’s pill has an advantage over Novo’s, which is that it can be taken at any time of day, with or without food. Lilly disclosed in a February regulatory filing that it had $1.5 billion worth of prelaunch inventory ready ahead of the FDA approval — which is about as much as analysts polled by FactSet expect it to sell this year.

Malaysia tightens export controls on US AI chips as Nvidia’s Jensen Huang heads to China

More Markets

With their recent surge, Intel shares just hit their highest level since the dot-com era

Netflix sinks following disappointing outlook as investors wait for more ad growth

Eli Lilly’s GLP-1 pill hit nearly 1,400 prescriptions in first week

Eli Lilly makes the world’s bestselling drug. Can it keep the party going?

Latest Stories